Document Detail


Silent ischemia: to treat or not.
MedLine Citation:
PMID:  2117847     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
As worded, the question "Should silent ischemia be treated?" needs to be examined carefully, assuming that silent ischemia is even the correct topic of the question. The way the question is phrased influences the answer. The more the question's permutations are examined, the clearer it becomes that the problem is one of definition. Our conceptualization of the ischemic process is still incomplete, and the question of whether to treat silent ischemia remains. Ultimately, the decision will depend on demonstrable benefit for prognosis. Every acute ischemic syndrome is indicative of poor prognosis, independent of other factors associated with adverse outcome and of the method of measurement. The true determinant of the need to treat is the total ischemic pattern, and how silent ischemia and angina fit within that context is not yet known.
Authors:
W E Shell
Related Documents :
3177297 - Sudden infant death and home monitors.
2528127 - Recent trends in the prevalence and secondary prevention of down's syndrome.
2400217 - Ethnic differences in incidence of sudden infant death syndrome in birmingham.
9288097 - A mouse model for zellweger syndrome.
24121647 - Effective masking levels for 500 and 2000 hz bone conduction auditory steady state resp...
6287827 - Maternity care monitoring in ibadan, nigeria.
Publication Detail:
Type:  Clinical Trial; Journal Article    
Journal Detail:
Title:  American heart journal     Volume:  120     ISSN:  0002-8703     ISO Abbreviation:  Am. Heart J.     Publication Date:  1990 Sep 
Date Detail:
Created Date:  1990-09-27     Completed Date:  1990-09-27     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  0370465     Medline TA:  Am Heart J     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  766-8; discussion 769-72     Citation Subset:  AIM; IM    
Affiliation:
Cardiology Division, Cedars-Sinai Medical Center, Los Angeles, CA 90210.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Clinical Trials as Topic
Coronary Disease / diagnosis,  physiopathology,  therapy*
Electrocardiography, Ambulatory
Exercise Test
Humans
Nifedipine / therapeutic use
Nitroglycerin / therapeutic use
Chemical
Reg. No./Substance:
21829-25-4/Nifedipine; 55-63-0/Nitroglycerin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Angina: evolution of the role of nitrates.
Next Document:  Evaluation and therapy of the patient with fecal occult blood loss: a decision analysis.